Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Clinical trial NCT07441408 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07441408
- Sponsor
- Bristol-Myers Squibb
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-16
- Primary completion
- 2029-11-22
- Enrollment
- 2380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.